KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 1021223 LOS ANGELES, CA

Back to UTHR Full portfolio

Position in UTHR

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$1,185

+$211 QoQ

Shares Held

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

6 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in UTHR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC holds $146,457,732 across 6 Drug Manufacturers - Specialty & Generic names. UTHR ranks #6 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PBH	Prestige Consumer Healthcare Inc.	2,202,606	$130,548,456
2	HLN	Haleon plc	1,583,730	$15,853,137
3	ZTS	Zoetis Inc.	383	$45,274
4	VTRS	Viatris Inc	614	$8,295
5	PRGO	PERRIGO Co plc	129	$1,385
6	UTHR	UNITED THERAPEUTICS Corp This page	2	$1,185

All Filings in UTHR

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,185	2	0.0%	Shares	Sole	2026-05-14
2025-12-31	$974	2	0.0%	Shares	Sole	2026-02-13
2025-09-30	$838	2	0.0%	Shares	Sole	2025-11-13
2025-06-30	$574	2	-94.3%	Shares	Sole	2025-08-13
2024-09-30	$12,542	35	+218.2%	Shares	Sole	2024-11-13
2022-03-31	$1,973	11	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.